PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Novo Nordisk Inc., a global healthcare company and leader in diabetes care, has been recognized as the "Best Place to Work in New Jersey" by NJBiz, the state's largest weekly business newspaper. This is the fourth time in six years the company has achieved this honor. Earlier this year, the company was recognized for the second consecutive year as one of FORTUNE's "100 Best Companies to Work For."
"It is an honor for Novo Nordisk to be named the #1 Best Place to Work in New Jersey four of the last six years," said Jeff Frazier, vice president of human resources. "The sustained level of employee engagement that enables us to maintain such a high ranking is indicative of our employees' commitment to our triple bottom line, as well as the company's mission to change diabetes and help people living with the diseases we treat."
The ranking is based on an independent assessment of policies, practices and demographics as well as a comprehensive employee survey.
In the survey, employees expressed a high level of satisfaction with their work environment. Nearly all of those surveyed had positive responses to the statements, "I would recommend my company's products/services to a friend," "I am willing to give extra effort to help my company succeed," and "I can trust what this organization tells me."
Novo Nordisk's recognition can be attributed in part to unique programs like College Coach, which helps parents navigate how to finance their children's college education. A recently launched program called "I am Novo Nordisk" affirms employees' positive responses to such programs. In "I am Novo Nordisk," employees who exemplify the company's values share their stories about why they love working for the company.
The "Best Place to Work in New Jersey" award is part of the weekly publication's annual survey to honor the companies in New Jersey that show a dedication to their employees' growth and quality of life, which was published in a supplement to the April 26 issue and online at www.njbiz.com.
About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.
SOURCE Novo Nordisk Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here